Valeda ™ is the first photobiomodulation (PBM) device designed specifically for eye conditions such as dry age-related macular degeneration.
What is age-related macular degeneration?
Age-related macular degeneration (AMD) is a common condition affecting older people and usually starting around 50-60 years of age. This condition results in deterioration of the central part of your vision when the macular retina develops lesions. There are two main types called dry and wet AMD. Dry age-related macular degeneration is more common than wet AMD. Dry AMD is caused by the build up of drusen, which a fatty deposit, at the back of the eye or retina. Wet AMD is caused by the growth of abnormal blood vessels at the back of the eye.
Valeda ™ Light Delivery System
The Valeda ™ Light Delivery System (LDS) was developed by LumiThera. The system is the first approved treatment for dry age-related macular degeneration (AMD) using photobiomodulation (PBM). PBM has been around for a long time and used for number of different conditions including muscle repair; wound healing; improve muscle performance and many other applications. PMB uses light to stimulate cells. This stimulates energy production within cells improving their function.
Frequently Asked Questions